000 01478 a2200397 4500
005 20250513083957.0
264 0 _c19960216
008 199602s 0 0 eng d
022 _a1079-5642
024 7 _a10.1161/01.atv.16.1.89
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSironi, L
245 0 0 _aPlasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL.
_h[electronic resource]
260 _bArteriosclerosis, thrombosis, and vascular biology
_cJan 1996
300 _a89-96 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCarcinoma, Hepatocellular
_xmetabolism
650 0 4 _aCulture Media, Conditioned
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLipoproteins, VLDL
_xpharmacology
650 0 4 _aLiver Neoplasms
_xmetabolism
650 0 4 _aPlasminogen Activator Inhibitor 1
_xbiosynthesis
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aReceptors, LDL
_xphysiology
650 0 4 _aTriglycerides
_xmetabolism
650 0 4 _aTumor Cells, Cultured
700 1 _aMussoni, L
700 1 _aPrati, L
700 1 _aBaldassarre, D
700 1 _aCamera, M
700 1 _aBanfi, C
700 1 _aTremoli, E
773 0 _tArteriosclerosis, thrombosis, and vascular biology
_gvol. 16
_gno. 1
_gp. 89-96
856 4 0 _uhttps://doi.org/10.1161/01.atv.16.1.89
_zAvailable from publisher's website
999 _c8547507
_d8547507